Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Artemis Medicare Services Limited (ARTEMISMED.NS)
Gurugram, HR, IN
Artemis Medicare Services Limited engages in the management and operation of multi-specialty hospitals in India and internationally. The company provides medical and surgical intervention, and inpatient and outpatient services. It also offers billing and insurance, childcare, emotional and support program, full body checkup, international patient, medical interpreter and record, mind body medicine, nursing, nutrition, patient and family advisory, patient advocacy and portal, pre-admission testing, and smoking cessation program services, as well as home care services. Artemis Medicare Services Limited was incorporated in 2004 and is based in Gurugram, India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.77% | +1.84% | +17.70% | +12.40% | -1.41% | -0.90% | +8.20% | +213.79% | +861.35% | +1,089.55% | +1,089.55% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+15.4% ★ Q1'26: +16.4% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+23.5% ★ Q1'26: +31.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+3.4% Q1'26: +4.9% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+13.0% ★ Q1'26: +9.6% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+10.5% ★ Q1'26: +8.1% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+1.5% Q1'26: -0.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×1.39× ★ Q1'26: 1.57× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 2 Rev. Ana. 1 EPS Ana. |
Mar 2027 3 Rev. Ana. 1 EPS Ana. |
Mar 2028 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|
| Revenue |
8.79B
est: 8.92B (-1.5%)
|
9.37B
est: 9.47B (-1.1%)
|
10.78B
10.75B – 10.81B
+13.8% YoY
|
13.09B
11.51B – 14.24B
+21.5% YoY
|
15.21B
12.07B – 17.41B
+16.1% YoY
|
| EBITDA |
1.25B
est: 2.03B (-38.7%)
|
1.52B
est: 2.16B (-29.7%)
|
2.46B
2.45B – 2.46B
+13.8% YoY
|
2.98B
2.62B – 3.24B
+21.5% YoY
|
3.46B
2.75B – 3.97B
+16.1% YoY
|
| EBIT |
934.57M
est: 1.58B (-40.8%)
|
1.07B
est: 1.68B (-36.4%)
|
1.91B
1.90B – 1.91B
+13.8% YoY
|
2.32B
2.04B – 2.52B
+21.5% YoY
|
2.69B
2.14B – 3.08B
+16.1% YoY
|
| Net Income |
491.41M
est: 559.89M (-12.2%)
|
826.26M
est: 872.38M (-5.3%)
|
1.04B
815.68M – 1.20B
+18.8% YoY
|
1.34B
1.30B – 1.42B
+29.0% YoY
|
1.97B
1.91B – 2.04B
+47.7% YoY
|
| SGA |
85.22M
est: 207.69M (-59.0%)
|
109.15M
est: 220.50M (-50.5%)
|
250.94M
250.14M – 251.74M
+13.8% YoY
|
304.77M
267.90M – 331.47M
+21.5% YoY
|
353.97M
281.01M – 405.37M
+16.1% YoY
|
| EPS |
3.62
est: 4.05 (-10.6%)
|
5.37
est: 5.40 (-0.6%)
|
6.60
5.16 – 7.62
+22.2% YoY
|
8.60
8.24 – 8.96
+30.3% YoY
|
12.50
12.09 – 12.91
+45.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Devlina Chakravarty DMRD Radiology | Chief Executive Officer, MD & Executive Director | 369M | — |
| Flight Lieutenant Saras Malik | Chief People Officer of Human Resources & Training | — | — |
| Manju Aggarwal MBBS | Chief Medical Services & Chairperson of Nephrology | — | — |
| Poonam Makkar | Company Secretary & Compliance Officer | — | female |
| Pradeep Kumar Saha | Group Chief Information Officer | — | male |
| Rudra Narayan Acharjee | Head of Investor Relations, M&A and Organization Growth Strategy | — | male |
| Sanjiv Kumar Kothari | Chief Financial Officer | — | male |
| Vivek Singh | Head of Legal | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ARTEMISMED.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
